Earnings Preview: AngioDynamics (ANGO) Q1 Earnings Expected to DeclineZacks Investment Research • 09/22/20
AngioDynamics Announces Commercial Launch of Auryon Atherectomy System in United StatesBusiness Wire • 09/21/20
AngioDynamics to Report Fiscal 2021 First Quarter Financial Results on September 29, 2020Business Wire • 09/17/20
AngioDynamics Announces First Patient Enrolled in PATHFINDER I Registry Examining Long-Term Effectiveness and Safety of Auryon Atherectomy SystemBusiness Wire • 08/17/20
Why Is AngioDynamics (ANGO) Down 1.3% Since Last Earnings Report?Zacks Investment Research • 08/15/20
AngioDynamics to Participate in a Virtual Fireside Chat at the Canaccord Genuity Growth ConferenceBusiness Wire • 08/03/20
AngioDynamics' (ANGO) CEO Jim Clemmer on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 07/16/20
AngioDynamics Reports Fiscal 2020 Fourth Quarter and Full-Year Financial ResultsBusiness Wire • 07/16/20
AngioDynamics (ANGO) Down 1.6% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 05/07/20
AngioDynamics, Inc. (ANGO) CEO Jim Clemmer on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 04/07/20
AngioDynamics (ANGO) Upgraded to Buy: Here's What You Should KnowZacks Investment Research • 03/25/20
AngioDynamics (ANGO) Down 10.4% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 02/06/20
AngioDynamics, Inc. (ANGO) CEO Jim Clemmer on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 01/07/20
Earnings Preview: AngioDynamics (ANGO) Q2 Earnings Expected to DeclineZacks Investment Research • 12/31/19